logo

For the Inventor, By the Inventor

The Woodlands, TX, United States of America

Repros Therapeutics Inc.


USPTO Granted Patents = 22

% Expired Patents = 81.8



Trademarks = 1

Forward Citations = 72

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Joseph S Podolski (20 out of 36 patents)

silverMedal Ronald D Wiehle (8 out of 8 patents)

bronzeMedal Kuang T Hsu (4 out of 12 patents)

4.  Greg Fontenot (2 out of 2 patents)

5.  Andre Van As (2 out of 2 patents)

6.  Jaye Thompson (1 out of 1 patent)

7.  Kuang Hsu (2 patents)

8.  André Van As (0 patent)


22 patents:

1. 10561624 - Methods and materials for the treatment of testosterone deficiency in men (2020-02-18),
2. 10328022 - Formulations and methods for vaginal delivery of antiprogestins (2019-06-25),
3. 9981906 - Trans-clomiphene metabolites and uses thereof (2018-05-29),
4. 9914696 - Clomiphene synthesis using a single solvent (2018-03-13),
5. 9687458 - Trans-clomiphene for use in cancer therapy (2017-06-27),
6. 9616074 - Compositions and methods for suppressing endometrial proliferation (2017-04-11),
7. 9616034 - Trans-clomiphene and its analogues as agents that increase bone mineral density (2017-04-11),
8. 9545411 - Methods and compositions for treating progesterone-dependent conditions (2017-01-17),
9. 9283234 - Compositions and methods for suppressing endometrial proliferation (2016-03-15),
10. 9161940 - Selective estrogen receptor modulators with short half-lives and uses thereof (2015-10-20),
11. 8735381 - Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc (2014-05-27),
12. 8618176 - Methods and materials for the treatment of testosterone deficiency in men (2013-12-31),
13. 8519004 - Dosing regimes for trans-clomiphene (2013-08-27),
14. 8426394 - Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc (2013-04-23),
15. 8377991 - Trans-clomiphene for metabolic syndrome (2013-02-19),
Company Overview
Repros Therapeutics Inc. is a biopharmaceutical company based in The Woodlands, Texas, focused on developing innovative therapies for unmet medical needs. The organization specializes in the research and development of treatments for reproductive health and endocrine disorders, leveraging its expertise in hormonal modulation. Repros aims to address significant health challenges through its proprietary drug candidates, contributing to advancements in therapeutic options for patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#21 in The Woodlands, TX

#890 in Texas

#15,037 in US

#28,782 in the World

The Woodlands, TX (US)
The Woodlands, TX, United States of America

Repros Therapeutics Inc.

Forward Citations = 72

6 inventors:

goldMedal Joseph S Podolski (20 out of 36 patents)

silverMedal Ronald D Wiehle (8 out of 8 patents)

bronzeMedal Kuang T Hsu (4 out of 12 patents)

4.  Greg Fontenot (2 out of 2 patents)

5.  Andre Van As (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Repros Therapeutics Inc.. Retrieved from https://idiyas.com/company/repros-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…